" "
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Molecular Devices to Showcase Next Generation SpectraMax® MiniMax™ 300 Imaging Cytometer at Analytica

Published: Wednesday, March 19, 2014
Last Updated: Wednesday, March 19, 2014
Bookmark and Share
SpectraMax® MiniMax™ 300 imaging cytometer enables both cellular visualization and first-of-its-kind stain free cell-based analysis on the field-upgradable SpectraMax®i3 Multi-Mode Microplate Reader.

Also on show, enabling both ELISAs and Western Blot on one plate reader, the new ScanLater™ Western Blot Detection System is the first western blot application for a microplate reader.

The SpectraMax MiniMax 300 Imaging Cytometer now features the patent-pending StainFree™ Cell Detection algorithm, which enables cell confluency and cell counting measurements on an imaging plate reader without the need for destructive stains, saving researchers valuable time and money. With two additional fluorescence detection channels; green and red, researchers may now perform and analyze a wide range of cellular viability and cell toxicity assays, including ratiometric assays such as transfection efficiency. The SpectraMax i3 system offers three integrated detection modes; luminescence, absorbance, and fluorescence, while its flexible design enables a wide array of assay possibilities. The patented user-exchangeable cartridge design expands the system's detection capabilities with cartridges like the recently launched ScanLater™ Western Blot Detection System, which enables protein analysis on a plate reader. 

The SpectraMax i3 platform with MiniMax 300 Imaging Cytometer and ScanLater Western Blot System are all managed through SoftMax® Pro Data Acquisition and Analysis Software, recognized industry-wide for its ease of use. With simple to set-up plate reader prompts and pre-defined analysis features, results are realized and analyzed quickly. The SpectraMax i3 System is also available for use in GMP and GLP labs when used with SoftMax® Pro 6 GxP Microplate Data Compliance Software. The highly sensitive instrument accommodates the budget and throughput needs of both small and large laboratories alike. Combining cellular imaging with microplate-based applications offers new ways for scientists to compress their workflows and increase efficiency. 

Also on show will be the AquaMax® 4000, the 4-in-1 self-contained microplate washer system. The AquaMax® 4000 is one of a series of microplate washers. The unique modular design of this washer platform allows researchers to configure the system for their current microplate format and applications, and provides an affordable upgrade path when assay requirements change. The system's 96- and 384-well wash heads are interchangeable to extend the capabilities of the system on a single instrument platform.

The AquaMax system washes the wells of microplate-based biological assays, an integral component of life science research. Primary applications for this instrument include ELISA, immunoassays, and cytotoxicity assays, and many cell-based assays used in high-throughput screening during the drug discovery process. 

The system washes all wells in the microplate simultaneously, resulting in very fast microplate processing unlike conventional washers that sequentially fill wells by strip or quadrant dispensing. On-board, touch-screen programming gives researchers a high degree of control over microplate processing parameters resulting in fast and efficient plate washing. The system's highly efficient washing capability minimizes background interference and maximizes assay sensitivity. A comprehensive cleaning routine prevents clogged dispense head and probes, the primary cause of microplate washer failure. Unlike competitive instruments, AquaMax is completely self-contained and does not require external pumps or computers resulting in significant time and cost saving over conventional wash systems.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors
The new Board will support the Company’s strategic focus on the discovery, development, and commercialization of radiopharmaceuticals for molecular imaging and targeted radiotherapy of prostate cancer.
Wednesday, February 29, 2012
Scientific News
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
The Spice of Life
Scientists discover important genetic source of human diversity.
Removing Race from Human Genetic Research
A group of scientists are urging their colleagues to take a step forward and stop using racial categories when researching and studying human genetics.
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH-funded study could lead to new tick control methods.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!